Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Partially Hydrolyzed Whey Formula in Cow's Milk Allergic Patients
Partially Hydrolyzed Whey Formula in Cow's Milk Allergic Patients
Status: Enrolling
Updated:  12/6/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Partially Hydrolyzed Whey Formula in Cow's Milk Allergic Patients
Partially Hydrolyzed Whey Formula in Cow's Milk Allergic Patients
Status: Enrolling
Updated: 12/6/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
AMES + Brain Stimulation
AMES + Brain Stimulation: Treatment for Profound Plegia in Stroke
Status: Enrolling
Updated:  12/7/2016
Oregon Health and Science University
mi
from
Portland, OR
AMES + Brain Stimulation
AMES + Brain Stimulation: Treatment for Profound Plegia in Stroke
Status: Enrolling
Updated: 12/7/2016
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
AMES Treatment of the Impaired Leg in Chronic Stroke Patients
AMES Treatment of the Impaired Leg in Chronic Stroke Patients
Status: Enrolling
Updated:  12/7/2016
Northwestern University/Rehabilitation Institute of Chicago
mi
from
Chicago, IL
AMES Treatment of the Impaired Leg in Chronic Stroke Patients
AMES Treatment of the Impaired Leg in Chronic Stroke Patients
Status: Enrolling
Updated: 12/7/2016
Northwestern University/Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
AMES Treatment of the Impaired Leg in Chronic Stroke Patients
AMES Treatment of the Impaired Leg in Chronic Stroke Patients
Status: Enrolling
Updated:  12/7/2016
Oregon Health and Science University
mi
from
Portland, OR
AMES Treatment of the Impaired Leg in Chronic Stroke Patients
AMES Treatment of the Impaired Leg in Chronic Stroke Patients
Status: Enrolling
Updated: 12/7/2016
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Sarasota, FL
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Atlanta, GA
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Northbrook, IL
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Northbrook, IL
Click here to add this to my saved trials
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Rochester, MN
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Patchogue, NY
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Patchogue, NY
Click here to add this to my saved trials
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Raleigh, NC
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Franklin, TN
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Franklin, TN
Click here to add this to my saved trials
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Dallas, TX
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Kirkland, WA
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Kirkland, WA
Click here to add this to my saved trials
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Aurora, CO
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Lincoln, NE
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Lincoln, NE
Click here to add this to my saved trials
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Albuquerque, NM
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Cleveland, OH
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Clinic-Based AMES Treatment of Stroke
Clinic-Based Assisted Movement and Enhanced Sensation Treatment of Stroke
Status: Enrolling
Updated:  12/7/2016
Oregon Health & Science University Center for Health & Healing
mi
from
Portland, OR
Clinic-Based AMES Treatment of Stroke
Clinic-Based Assisted Movement and Enhanced Sensation Treatment of Stroke
Status: Enrolling
Updated: 12/7/2016
Oregon Health & Science University Center for Health & Healing
mi
from
Portland, OR
Click here to add this to my saved trials
Effect of IV Acetaminophen on Patients in the Neurocritical Care Unit
Status: Enrolling
Updated:  12/8/2016
University of Utah
mi
from
Salt Lake City, UT
Effect of IV Acetaminophen on Patients in the Neurocritical Care Unit
Status: Enrolling
Updated: 12/8/2016
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
Status: Enrolling
Updated:  12/12/2016
Carolinas Medical Center NorthEast Medical Arts Building
mi
from
Concord, NC
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
Status: Enrolling
Updated: 12/12/2016
Carolinas Medical Center NorthEast Medical Arts Building
mi
from
Concord, NC
Click here to add this to my saved trials
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
Status: Enrolling
Updated:  12/12/2016
Ada Jenkins Center
mi
from
Davidson, NC
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
Status: Enrolling
Updated: 12/12/2016
Ada Jenkins Center
mi
from
Davidson, NC
Click here to add this to my saved trials
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
Status: Enrolling
Updated:  12/12/2016
The Stedman Center on the Duke Center for Living Campus
mi
from
Durham, NC
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
Status: Enrolling
Updated: 12/12/2016
The Stedman Center on the Duke Center for Living Campus
mi
from
Durham, NC
Click here to add this to my saved trials
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
Status: Enrolling
Updated:  12/12/2016
Kannapolis Internal Medicine
mi
from
Kannapolis, NC
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
Status: Enrolling
Updated: 12/12/2016
Kannapolis Internal Medicine
mi
from
Kannapolis, NC
Click here to add this to my saved trials
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
Status: Enrolling
Updated:  12/12/2016
Raleigh Neurology Associates
mi
from
Raleigh, NC
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
Status: Enrolling
Updated: 12/12/2016
Raleigh Neurology Associates
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
Phoenix, AZ
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
Tucson, AZ
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
La Jolla, CA
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
Los Angeles, CA
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
Orange, CA
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
San Francisco, CA
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
Stanford, CA
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
Stanford, CA
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
New Haven, CT
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
Sarasota, FL
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
Tampa, FL
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
Atlanta, GA
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
Chicago, IL
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
Indianapolis, IN
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
Boston, MA
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
Burlington, MA
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
Burlington, MA
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
Minneapolis, MN
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
Rochester, MN
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
Morristown, NJ
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
Morristown, NJ
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
Farmington, NM
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
Farmington, NM
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
New Hyde Park, NY
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
New York, NY
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
Durham, NC
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated:  12/12/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Status: Enrolling
Updated: 12/12/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials